Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | 7819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| (2R,3R)-E1R | C13H16N2O2 | 1400888-63-2 | Details |
| E1R | C13H16N2O2 | 1301211-78-8 | Details |
| 2',5'-Dideoxyadenosine | C10H13N5O2 | 6698-26-6 | Details |
| PF-592379 | C13H21N3O | 710655-15-5 | Details |
| Anti-inflammatory agent 1 | C17H16O3S | 1096621-42-9 | Details |
| DT-061 | C25H23F3N2O5S | 1809427-19-7 | Details |
| 2614W94 | C15H11F3O4S | 205187-35-5 | Details |
| A2B receptor antagonist 1 | C21H24N6O2 | 531506-36-2 | Details |
| (2R,3S)-E1R | C13H16N2O2 | 1424832-60-9 | Details |
| 3-Carene | C10H16 | 13466-78-9 | Details |
| 3-Bromocytisine | C11H13BrN2O | 207390-14-5 | Details |
| 3-Bromo-7-nitroindazole | C7H4BrN3O2 | 74209-34-0 | Details |
| 3-arylisoquinolinamine derivative | C18H19N3O | 1029008-71-6 | Details |
| Cephalexin | C16H17N3O4S | 15686-71-2 | Details |
| 20(S)-Hydroxycholesterol | C27H46O2 | 516-72-3 | Details |
| 24-Hydroxycholesterol | C27H46O2 | 30271-38-6 | Details |
| Estrone | C18H22O2 | 53-16-7 | Details |
| 24R-Calcipotriol；PRI 2202 | C27H40O3 | 112827-99-3 | Details |
| 2',3'-cGAMP；2'-3'-cyclic GMP-AMP | C20H24N10O13P2 | 1441190-66-4 | Details |
| (1S,2S)-Bortezomib | C19H25BN4O4 | 1132709-14-8 | Details |
| Amoxicillin trihydrate | C16H21N3O6S | 61336-70-7 | Details |
| 2-Methyl-5-HT；2-Methyl-5-hydroxytryptamine | C11H14N2O | 78263-90-8 | Details |
| LH secretion antagonist 1 | C18H24ClNO2 | 88531-67-3 | Details |
| Itch-Targeting Compound 1 | C25H36ClN3O3 | 793674-76-7 | Details |
| Calcium channel-modulator-1 | C26H24Cl2N2O7S | 136941-70-3 | Details |
| 3,4-Dihydroxybenzylamine hydrobromide | C7H10BrNO2 | 16290-26-9 | Details |
| Verapamil hydrochloride | C27H39ClN2O4 | 152-11-4 | Details |
| 2-Methylcitric acid trisodium；Methylcitric acid trisodium | C7H7O7*3Na | 117041-96-0 | Details |
| 2-Methylcitric acid；Methylcitric acid | C7H10O7 | 6061-96-7 | Details |
| Nanofin | C7H15N | 504-03-0 | Details |
| Propantheline bromide | C23H30BrNO3 | 50-34-0 | Details |
| Thrombin inhibitor 1 | C22H20Cl2F2N4O3 | 855998-46-8 | Details |
| AMPK activator 1 | C32H33F3N4O3 | 1152423-98-7 | Details |
| 2'-Azido-2'-deoxyuridine；N3dUrd | C9H11N5O5 | 26929-65-7 | Details |
| 2-Hydroxy Ibuprofen；(±)-2-Hydroxy Ibuprofen | C13H18O3 | 51146-55-5 | Details |
| Itraconazole | C35H38Cl2N8O4 | 84625-61-6 | Details |
| 3-Hydroxy agomelatine | C15H17NO3 | 166526-99-4 | Details |
| 3-Nitrocoumarin | C9H5NO4 | 28448-04-6 | Details |
| 3-Hydroxy-4-methoxyacetophenone | C9H10O3 | 6100-74-9 | Details |
| 3-O-Acetylbufotalin | C28H38O7 | 4029-69-0 | Details |
| (3S,5R)-Fluvastatin sodium；(3S,5R)-XU 62-320 | C24H25FNNaO4 | 94061-81-1 | Details |
| (3R,5S)-Atorvastatin sodium | C33H34FN2O5.Na | 131275-93-9 | Details |
| 3-O-Methyltolcapone；Ro 40-7591 | C15H13NO5 | 134612-80-9 | Details |
| Amikacin | C22H43N5O13 | 37517-28-5 | Details |
| (3R,4R)-A2-32-01 | C19H27NO2 | 1359752-95-6 | Details |
| (3R,5R)-Rosuvastatin | C22H28FN3O6S | 1094100-06-7 | Details |
| Acebutolol hydrochloride | C18H29ClN2O4 | 34381-68-5 | Details |
| (3S,5R)-Rosuvastatin | C22H28FN3O6S | 1242184-42-4 | Details |
| (3S,5R)-Pitavastatin calcium | C25H26CaFNO4 | 254452-88-5 | Details |
| (3S,5S)-Pitavastatin calcium | C25H26CaFNO4 | 254452-92-1 | Details |
| 4-Acetamidophenyl acetate | C10H11NO3 | 2623-33-8 | Details |
| 4-Hydroxyacetophenone oxime | C8H9NO2 | 34523-34-7 | Details |
| p-Ethynylphenylalanine | C11H11NO2 | 278605-15-5 | Details |
| 4-Acetylsimvastatin | C27H40O6 | 145576-25-6 | Details |
| 4-Diethylaminobenzaldehyde | C11H15NO | 120-21-8 | Details |
| 4-Desmethoxy Omeprazole | C16H17N3O2S | 110374-16-8 | Details |
| 4-Desmethyl Istradefylline | C19H22N4O4 | 160434-48-0 | Details |
| 3-Deazaadenosine | C11H14N4O4 | 6736-58-9 | Details |
| 3-Deazaadenosine hydrochloride | C11H15ClN4O4 | 86583-19-9 | Details |
| 3-Oxo Atorvastatin | C33H33FN2O5 | 887196-30-7 | Details |
| Substance P Receptor Antagonist 1 | C24H29F3N2O2 | 225526-17-0 | Details |
| 4-Hydroxyatomoxetine | C17H21NO2 | 435293-66-6 | Details |
| 4-Hydroxyatomoxetine D3 | C17H21NO2 | 1217686-14-0 | Details |
| 4'-Ethynyl-2'-deoxyadenosine | C12H13N5O3 | 306305-07-7 | Details |
| 4,7,10,13,16-Docosapentaenoic acid | C22H34O2 | 2313-14-6 | Details |
| 3'-Azido-3'-deoxy-5-methylcytidine | C10H14N6O4 | 1282040-14-5 | Details |
| Anti-neurodegeneration agent 1 | C14H20ClN3O3 | 289893-23-8 | Details |
| VEGFR-2-IN-9；KDR-in-4 | C23H25N3O3 | 408502-06-7 | Details |
| (3S,5R)-Fluvastatin D6 sodium；(3S,5R)-XU 62-320 D6 | C24H27FNNaO4 | 2249799-35-5 | Details |
| 3-CPs | C14H10O5 | 20073-24-9 | Details |
| 2'-Ethyl Simvastatin | C23H34O5 | 79902-42-4 | Details |
| 2',5-Difluoro-2'-deoxycytidine | C9H11F2N3O4 | 581772-30-7 | Details |
| LDL-IN-3 | C24H36O3Si | 180908-67-2 | Details |
| QF0301B | C23H28N2O2 | 149247-12-1 | Details |
| 3α-Hydroxymogrol | C30H52O4 | 1343402-73-2 | Details |
| 2-Keto-D-Glucose；D-Glucosone | C6H10O6 | 1854-25-7 | Details |
| (2S,3R)-Voruciclib | C22H19ClF3NO5 | 1253731-24-6 | Details |
| 2-Iodomelatonin | C13H15IN2O2 | 93515-00-5 | Details |
| 2-Methyl-5-HT maleate；2-Methylserotonin maleate;2-Methyl-5-hydroxytryptamine maleate;2-Me-HT maleate | C15H18N2O5 | 78263-91-9 | Details |
| 2-Methyl-5-HT hydrochloride；2-Methyl-5-hydroxytryptamine hydrochloride | C11H15ClN2O | 845861-49-6 | Details |
| 24-Norursodeoxycholic acid | C23H38O4 | 99697-24-2 | Details |
| (1S,2S,3R)-DT-061 | C25H23F3N2O5S | 1809427-20-0 | Details |
| Desethyl KBT-3022 | C23H20N2O4S | 101001-72-3 | Details |
| 2'-Deoxypseudoisocytidine | C9H13N3O4 | 65358-18-1 | Details |
| (2R,4R)-APDC | C6H10N2O4 | 169209-63-6 | Details |
| CRTh2 antagonist 1 | C23H25N3O5S | 1379445-54-1 | Details |
| (-)-GSK598809；1S,5R-GSK598809 | C22H23F4N5OS | 863680-46-0 | Details |
| 264W94 | C23H31NO4S | 178961-24-5 | Details |
| MAO-IN-1 | C17H19ClO4 | 124991-40-8 | Details |
| PSN-GK1 | C20H23FN2O4S2 | 745051-61-0 | Details |
| 3'-O-Acetylhamaudol | C17H18O6 | 30358-88-4 | Details |
| 3-Hydroxy agomelatine D3 | C15H17NO3 | 1079774-23-4 | Details |
| (2S,3S)-E1R | C13H16N2O2 | 1424832-57-4 | Details |
| 2-O-β-D-Glucopyranosyl-L-ascorbic acid；AA-2βG | C12H18O11 | 562043-82-7 | Details |
| 4-Bromo A23187；4-?Bromo A23187 | C29H36BrN3O6 | 76455-48-6 | Details |
| Antiulcer Agent 1 | C19H23N3O4 | 76001-09-7 | Details |
| PGS-IN-1 | C19H26O3 | 102271-49-8 | Details |
| 3,3'-Diiodo-L-thyronine；3,3'-T2 | C15H13I2NO4 | 4604-41-5 | Details |
| Neuromuscular Disorder-Targeting Compound 1 | C15H25N3S | 374538-23-5 | Details |
| DPP-IV-IN-1 | C11H18FN3O2 | 625110-37-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 | ||||